247 related articles for article (PubMed ID: 20439388)
1. Dysregulation of regional endogenous opioid function in borderline personality disorder.
Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR
Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
Kennedy SE; Koeppe RA; Young EA; Zubieta JK
Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
Love TM; Stohler CS; Zubieta JK
Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers.
Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK
Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535
[TBL] [Abstract][Full Text] [Related]
6. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
[TBL] [Abstract][Full Text] [Related]
7. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
10. Borderline personality disorder, impulsivity, and the orbitofrontal cortex.
Berlin HA; Rolls ET; Iversen SD
Am J Psychiatry; 2005 Dec; 162(12):2360-73. PubMed ID: 16330602
[TBL] [Abstract][Full Text] [Related]
11. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
[TBL] [Abstract][Full Text] [Related]
12. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder.
Silbersweig D; Clarkin JF; Goldstein M; Kernberg OF; Tuescher O; Levy KN; Brendel G; Pan H; Beutel M; Pavony MT; Epstein J; Lenzenweger MF; Thomas KM; Posner MI; Stern E
Am J Psychiatry; 2007 Dec; 164(12):1832-41. PubMed ID: 18056238
[TBL] [Abstract][Full Text] [Related]
13. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain functional connectivity during script-driven aggression in borderline personality disorder.
Ueltzhöffer K; Herpertz SC; Krauch M; Schmahl C; Bertsch K
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():46-54. PubMed ID: 30885789
[TBL] [Abstract][Full Text] [Related]
15. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
[TBL] [Abstract][Full Text] [Related]
16. Altered central micro-opioid receptor binding after psychological trauma.
Liberzon I; Taylor SF; Phan KL; Britton JC; Fig LM; Bueller JA; Koeppe RA; Zubieta JK
Biol Psychiatry; 2007 May; 61(9):1030-8. PubMed ID: 16945349
[TBL] [Abstract][Full Text] [Related]
17. Nonacceptance of negative emotions in women with borderline personality disorder: association with neuroactivity of the dorsal striatum.
Lamers A; Toepper M; Fernando SC; Schlosser N; Bauer E; Woermann F; Driessen M; Beblo T
J Psychiatry Neurosci; 2019 Sep; 44(5):303-312. PubMed ID: 30964611
[TBL] [Abstract][Full Text] [Related]
18. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
Nuechterlein EB; Ni L; Domino EF; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
[TBL] [Abstract][Full Text] [Related]
20. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
